ArticleAnnals of translational medicine2022

Cost-effectiveness analysis of vonoprazan versus proton pump inhibitors in the treatment of reflux esophagitis in China.

Zhenhua Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.